Skip to main content
NCBI home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1972 Dec;51(12):3044–3051. doi: 10.1172/JCI107131

The Role of Iron in the Pathogenesis of Porphyria Cutanea Tarda

AN IN VITRO MODEL

J P Kushner 1, G R Lee 1, S Nacht 1
PMCID: PMC332986  PMID: 4640947

Abstract

Porphyria cutanea tarda (PCT) is characterized biochemically by excessive hepatic synthesis and urinary excretion of uroporphyrin I. Clinical evidence has implicated iron in the pathogenesis of PCT. The synthesis of the normally occurring isomer of uroporphyrin, namely uroporphyrin III, from porphobilinogen (PBG) requires two enzymes; uroporphyrinogen I synthetase and uroporphyrinogen III cosynthetase (COSYN). In the absence of COSYN only uroporphyrinogen I is formed.

These experiments were designed to study the effect of iron on porphyrin biosynthesis in porcine and human crude liver extracts and to measure COSYN activity in the presence of iron.

Mitochondria-free crude liver extracts were prepared in 0.25 m sucrose at pH 7.4 by centrifugation at 37,000 g. Preparations were incubated with either 0.2 mm amino-levulinic acid (ALA) or 0.1 mm PBG. The addition of ferrous ion (either from ferritin iron [4 μg/ml] and cysteine [6.7 mm] or ferrous ammonium sulfate [0.3 mm Fe] and cysteine) significantly increased the rate of uroporphyrin synthesis from either ALA or PBG. The predominant porphyrin synthesized in the presence of ferrous ion was uroporphyrin I whereas coproporphyrin III predominated in its absence. Orthophenanthroline blocked these effects of ferrous ion.

To investigate the effect of ferrous ion on COSYN, crude liver extracts were incubated with ferrous ammonium sulfate (0.3 mm Fe) and cysteine (6.7 mm) and the COSYN activity of the incubates was assayed directly. In both porcine and human extracts ferrous ion caused marked inhibition of COSYN activity. Orthophenanthroline blocked the inhibitory effect.

Inactivation of COSYN by heating resulted in marked enhancement of porphyrin synthesis from PBG. The sole product was uroporphyrin I.

Thus, inactivation of COSYN results in accelerated synthesis of uroporphyrin I. This effect of ferrous ion provides a possible biochemical explanation for the excess production and excretion of uroporphyrin I in patients with PCT and the reversal of this defect by phlebotomy.

Full text

PDF
3044

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. BOGORAD L. The enzymatic synthesis of porphyrins from porphobilinogen. II. Uroporphyrin III. J Biol Chem. 1958 Aug;233(2):510–515. [PubMed] [Google Scholar]
  2. CORNFORD P. A., BENSON A. A qualitative and quantitative study of the separation of uroporphyrin octamethyl esters I and III by dioxan chromatography. J Chromatogr. 1963 Feb;10:141–157. doi: 10.1016/s0021-9673(01)92287-3. [DOI] [PubMed] [Google Scholar]
  3. DEAN G. THE PREVALENCE OF THE PORPHYRIAS. S Afr J Lab Clin Med. 1963 Dec;14:145–151. [PubMed] [Google Scholar]
  4. Dowdle E. B., Mustard P., Eales L. Delta-aminolaevulinic acid synthetase activity in normal and porphyric human livers. S Afr Med J. 1967 Nov 4;41(42):1093–1096. [PubMed] [Google Scholar]
  5. Dowdle E., Goldswain P., Spong N., Eales L. The pattern of porphyrin isomer accumulation and excretion in symptomatic porphyria. Clin Sci. 1970 Aug;39(2):147–158. doi: 10.1042/cs0390147. [DOI] [PubMed] [Google Scholar]
  6. EDMONDSON P. R., SCHWARTZ S. Studies of the uroporphyrins. III. An improved method for the decarboxylation of uroporphyrin. J Biol Chem. 1953 Dec;205(2):605–609. [PubMed] [Google Scholar]
  7. Epstein J. H., Pinski J. B. Porphyria cutanea tarda. Association with abnormal iron metabolism. Arch Dermatol. 1965 Oct;92(4):362–366. doi: 10.1001/archderm.92.4.362. [DOI] [PubMed] [Google Scholar]
  8. Epstein J. H., Redeker A. G. Porphyria cutanea tarda. A study of the effect of phlebotomy. N Engl J Med. 1968 Dec 12;279(24):1301–1304. doi: 10.1056/NEJM196812122792402. [DOI] [PubMed] [Google Scholar]
  9. Frydman R. B., Tomaro M. L., Frydman B. Pyrrolooxygenases: The biosynthesis of 2-aminoacetophenone. FEBS Lett. 1971 Oct 1;17(2):273–276. doi: 10.1016/0014-5793(71)80163-1. [DOI] [PubMed] [Google Scholar]
  10. Frydman Rosal'ia B., Tomaro María L., Frydman Benjamín. Pyrrolooxygenase: A new type of target enzyme. FEBS Lett. 1971 Jul 1;15(4):305–308. doi: 10.1016/0014-5793(71)80644-0. [DOI] [PubMed] [Google Scholar]
  11. IPPEN H. [General symptoms of late skin porphyria (porphyria cutanea tarda) as an indication for its treatment]. Dtsch Med Wochenschr. 1961 Jan 20;86:127–133. doi: 10.1055/s-0028-1112755. [DOI] [PubMed] [Google Scholar]
  12. Kalivas J. T., Pathak M. A., Fitzpatrick T. B. Phlebotomy and iron-overload in porphyria cutanea tarda. Lancet. 1969 Jun 14;1(7607):1184–1187. doi: 10.1016/s0140-6736(69)92167-9. [DOI] [PubMed] [Google Scholar]
  13. Kaufman L., Marver H. S. Biochemical defects in two types of human hepatic porphyria. N Engl J Med. 1970 Oct 29;283(18):954–958. doi: 10.1056/NEJM197010292831803. [DOI] [PubMed] [Google Scholar]
  14. LOWRY O. H., ROSEBROUGH N. J., FARR A. L., RANDALL R. J. Protein measurement with the Folin phenol reagent. J Biol Chem. 1951 Nov;193(1):265–275. [PubMed] [Google Scholar]
  15. Levin E. Y. Uroporphyrinogen 3 cosynthetase from mouse spleen. Biochemistry. 1968 Nov;7(11):3781–3788. doi: 10.1021/bi00851a001. [DOI] [PubMed] [Google Scholar]
  16. Lundvall O., Weinfeld A. Studies of the clinical and metabolic effects of phlebotomy treatment in porphyria cutanea tarda. Acta Med Scand. 1968 Sep;184(3):191–199. doi: 10.1111/j.0954-6820.1968.tb02443.x. [DOI] [PubMed] [Google Scholar]
  17. MAUZERALL D., GRANICK S. The occurrence and determination of delta-amino-levulinic acid and porphobilinogen in urine. J Biol Chem. 1956 Mar;219(1):435–446. [PubMed] [Google Scholar]
  18. Miyagi K., Cardinal R., Bossenmaier I., Watson C. J. The serum porphobilinogen and hepatic porphobilinogen deaminase in normal and porphyric individuals. J Lab Clin Med. 1971 Nov;78(5):683–695. [PubMed] [Google Scholar]
  19. Nacht S., San Martín de Viale L. C., Grinstein M. Human porphyria cutanea tarda. Isolation and properties of the urinary porphyrins. Clin Chim Acta. 1970 Mar;27(3):445–452. doi: 10.1016/0009-8981(70)90297-4. [DOI] [PubMed] [Google Scholar]
  20. Pluscec J., Bogorad L. A dipyrrylmethane intermediate in the enzymatic synthesis of uroporphyrinogen. Biochemistry. 1970 Nov 24;9(24):4736–4743. doi: 10.1021/bi00826a017. [DOI] [PubMed] [Google Scholar]
  21. Romeo G., Levin E. Y. Uroporphyrinogen 3 cosynthetase in human congenital erythropoietic porphyria. Proc Natl Acad Sci U S A. 1969 Jul;63(3):856–863. doi: 10.1073/pnas.63.3.856. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Sancovich H. A., Battle A. M., Grinstein M. Porphyrin biosynthesis. VI. Separation and purification of porphobilinogen deaminase and uroporphyrinogen isomerase from cow liver. Porphobilinogenase an allosteric enzyme. Biochim Biophys Acta. 1969 Sep 30;191(1):130–143. doi: 10.1016/0005-2744(69)90322-2. [DOI] [PubMed] [Google Scholar]
  23. Stella A. M., Parera V. E., Llambías E. B., Batlle A. M. Pyrrylmethane intermediates in the synthesis of uroporphyrinogen 3 by soybean callus porphobilinogenase. Biochim Biophys Acta. 1971 Dec 21;252(3):481–488. doi: 10.1016/0304-4165(71)90151-6. [DOI] [PubMed] [Google Scholar]
  24. Strand L. J., Felsher B. F., Redeker A. G., Marver H. S. Heme biosynthesis in intermittent acute prophyria: decreased hepatic conversion of porphobilinogen to porphyrins and increased delta aminolevulinic acid synthetase activity. Proc Natl Acad Sci U S A. 1970 Nov;67(3):1315–1320. doi: 10.1073/pnas.67.3.1315. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Thivolet J., Perrot H., Mallein R., Sabater P. Effets cliniques et biologiques des chélateurs dans la porphyrie cutanée tardive. Presse Med. 1968 Feb 17;76(8):367–370. [PubMed] [Google Scholar]
  26. UYS C. J., EALES L. THE HISTOPATHOLOGY OF THE LIVER IN ACQUIRED (SYMPTOMATIC) PORPHYRIA. S Afr J Lab Clin Med. 1963 Dec;14:190–197. [PubMed] [Google Scholar]
  27. Walsh J. R., Lobitz W. C., Jr, Mahler D. J., Kingery F. A. Phlebotomy therapy in cutaneous porphyria. Effect on iron and trace metals. Arch Dermatol. 1970 Feb;101(2):167–172. [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES